Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
27
Oct |
Blood Test Could Identify Smokers At Higher Risk For Heart Disease, UT Southwestern Researchers FindCategory: Smoking / Quit Smoking | Leave a Comment |
A simple blood test could someday quantify a smoker’s lung toxicity and danger of heart disease, researchers at UT Southwestern Medical Center have found. Nearly one in five adults in the U.S. smoke, and smoking-related medical expenses and loss of productivity exceeds $167 billion annually, according to the Centers for Disease Control and Prevention…
|
21
Jul |
Safety Concerns Regarding Usage And Future Implications Of New Nicotine Delivery ProductsCategory: Smoking / Quit Smoking | Leave a Comment |
Devices marketed as “electronic cigarettes” are in reality crude drug delivery systems for refined nicotine, posing unknown risks with little new benefits to smokers, according to tobacco control experts. In a “Perspective” published in the New England Journal of Medicine, researchers from the Legacy’s Steven A…
|
28
Aug |
Alexza’s Staccato® Nicotine Licensed To Cypress BioscienceCategory: Smoking / Quit Smoking | Leave a Comment |
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. (Nasdaq: CYPB). The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking…
|
7
Nov |
Electronic Cigarette Association Urges Unbiased Evaluation Of E-cigarettes As Debate Intensifies Around These DevicesCategory: Smoking / Quit Smoking | Leave a Comment |
As the debate heats up concerning the use of electronic cigarettes, Electronic Cigarette Association (ECA) President Matt Salmon today encouraged those involved in this discussion to carefully and honestly study how these devices work and recognize that the more than one million adult committed smokers, who use electronic cigarettes, are seeking an alternative to combustible cigarettes that contain a multitude of toxic, harmful chemicals.
|
20
Apr |
Determining If A Smoker Is At Risk For Lung Cancer By Testing UrineCategory: Smoking / Quit Smoking | Leave a Comment |
Researchers may have uncovered why lung cancer afflicts some smokers and not others, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009. “A history of smoking has always been thought of as a predictor of lung cancer, but it is actually not very accurate,” said Jian-Min Yuan, Ph.D., M.D., associate professor of public health at the University of Minnesota.